John W. Sweetenham, MD, is a medical oncologist at The Cleveland Clinic Taussig Cancer Center and is the director of Hematologic Malignancy Research at The Cleveland Clinic. His specialty interests include non-Hodgkin's lymphoma, Hodgkin's lymphoma, autologous stem cell transplantation, and hematologic malignancies.